Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
Abstract: The impact of corticosteroid therapy (CT) on efficacy of immune checkpoint inhibitors (ICI) is undefined in hepatocellular carcinoma (HCC). We evaluated whether CT administered at baseline (bCT) or concurrently with ICI (cCT) influences overall (OS), progression-free survival (PFS) and overall response rates (ORR) in 341 patients collected across 3 continents. Of 304 eligible patients, 78 (26%) received >10 mg prednisone equivalent daily either as bCT (n=14, 5%) or cCT (n=64, 21%). Indications for CT included procedure/prophylaxis (n=37, 47%), management of immune-related adverse event (n=27, 35%), cancer-related symptoms (n=8, 10%) or comorbidities (n=6, 8%). Neither overall CT, bCT nor cCT predicted for worse OS, PFS nor ORR in univariable and multivariable analyses (p>0.05). CT for cancer-related indications predicted for shorter PFS (p<0.001) and was associated with refractoriness to ICI (75% vs 33%, p=0.05) compared with cancer-unrelated indications. This is the first study to demonstrate that neither bCT nor cCT influence response and OS following ICI in HCC. Worse outcomes in CT recipients for cancer-related indications appear driven by the poor prognosis associated with symptomatic HCC
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Journal for ImmunoTherapy of Cancer. - 8 (2020) , e000726, ISSN: 2051-1426
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2020
- Creator
- DOI
-
10.1136/jitc-2020-000726
- URN
-
urn:nbn:de:bsz:25-freidok-1743948
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:49 PM CET
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pinato, David James
- Bettinger, Dominik
- Marron, Thomas U.
- Universität
Time of origin
- 2020
Other Objects (12)
Optimization of oncolytic viral therapy for hepatocellular carcinoma
Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
T cells in the heterogeneous tumour immune microenvironment of hepatocellular carcinoma: Implications for immune checkpoint inhibitor therapy
Molecular targeted therapy for hepatocellular carcinoma : bench to bedside ; 31 tables
Sorafenib response in hepatocellular carcinoma therapy : introducing new possibilities with Cdk5 inhibition
Dynamic CT angiography for therapy evaluation after transarterial chemoembolization of hepatocellular carcinoma
Management of hepatocellular carcinoma: from prevention to molecular targeted therapy : 35 tables
Multimodality Treatment for Early-Stage Hepatocellular Carcinoma: A Bridging Therapy for Liver Transplantation
Checkpoint responses in cancer therapy
Apparent diffusion coefficient can predict therapy response of hepatocellular carcinoma to transcatheter arterial chemoembolization
The tumor-penetrating iRGD improves therapy and diagnosis in preclinical hepatocellular carcinoma models
An inducible hepatocellular carcinoma model for preclinical evaluation of anti-angiogenic therapy in adult mice
Optimization of oncolytic viral therapy for hepatocellular carcinoma
Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
T cells in the heterogeneous tumour immune microenvironment of hepatocellular carcinoma: Implications for immune checkpoint inhibitor therapy
Molecular targeted therapy for hepatocellular carcinoma : bench to bedside ; 31 tables
Sorafenib response in hepatocellular carcinoma therapy : introducing new possibilities with Cdk5 inhibition
Dynamic CT angiography for therapy evaluation after transarterial chemoembolization of hepatocellular carcinoma
Management of hepatocellular carcinoma: from prevention to molecular targeted therapy : 35 tables
Multimodality Treatment for Early-Stage Hepatocellular Carcinoma: A Bridging Therapy for Liver Transplantation
Checkpoint responses in cancer therapy
Apparent diffusion coefficient can predict therapy response of hepatocellular carcinoma to transcatheter arterial chemoembolization
The tumor-penetrating iRGD improves therapy and diagnosis in preclinical hepatocellular carcinoma models
An inducible hepatocellular carcinoma model for preclinical evaluation of anti-angiogenic therapy in adult mice
Optimization of oncolytic viral therapy for hepatocellular carcinoma
Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
T cells in the heterogeneous tumour immune microenvironment of hepatocellular carcinoma: Implications for immune checkpoint inhibitor therapy
Molecular targeted therapy for hepatocellular carcinoma : bench to bedside ; 31 tables
Sorafenib response in hepatocellular carcinoma therapy : introducing new possibilities with Cdk5 inhibition
Dynamic CT angiography for therapy evaluation after transarterial chemoembolization of hepatocellular carcinoma
Management of hepatocellular carcinoma: from prevention to molecular targeted therapy : 35 tables
Multimodality Treatment for Early-Stage Hepatocellular Carcinoma: A Bridging Therapy for Liver Transplantation
Checkpoint responses in cancer therapy
Apparent diffusion coefficient can predict therapy response of hepatocellular carcinoma to transcatheter arterial chemoembolization
The tumor-penetrating iRGD improves therapy and diagnosis in preclinical hepatocellular carcinoma models